Literature DB >> 21388142

Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor-ligand interactions.

Nuska Tschammer1, Jan Elsner, Angela Goetz, Katharina Ehrlich, Stefan Schuster, Miriam Ruberg, Julia Kühhorn, Dawn Thompson, Jennifer Whistler, Harald Hübner, Peter Gmeiner.   

Abstract

Heterocyclic dopamine surrogates of types 5 and 7 were synthesized and investigated for their dopaminergic properties. The enantiomerically pure biphenylcarboxamide (S)-5a displayed an outstanding K(i) of 27 pM at the agonist-labeled D(3) receptor and significant selectivity over the D(2) subtype. Measurement of [(35)S]GTPγS incorporation in the presence of a coexpressed PTX-insensitive G(α0-1) subunit indicated highly efficient G-protein coupling. Comparison of ligand efficacy data from cAMP accumulation and [(3)H]thymidine incorporation experiments revealed that ligand biased signaling is exerted by the test compound (S)-5a. Starting from the D(3) crystal structure, a combination of homology modeling and site directed mutagenesis gave valuable insights into the binding mode and the intermolecular origins of stereospecific receptor recognition. According to these data, the superior affinity of the eutomer 5a is caused by the favorable binding energy that results from interaction between the ligand's central ammonium unit and the aspartate residue in position 3.32 of the receptor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388142     DOI: 10.1021/jm101639t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 3.  Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design.

Authors:  Thomas M Keck; Caitlin Burzynski; Lei Shi; Amy Hauck Newman
Journal:  Adv Pharmacol       Date:  2014

4.  Structure-Based Design and Discovery of New M2 Receptor Agonists.

Authors:  Inbar Fish; Anne Stößel; Katrin Eitel; Celine Valant; Sabine Albold; Harald Huebner; Dorothee Möller; Mary J Clark; Roger K Sunahara; Arthur Christopoulos; Brian K Shoichet; Peter Gmeiner
Journal:  J Med Chem       Date:  2017-11-13       Impact factor: 7.446

Review 5.  Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.

Authors:  Amy Hauck Newman; Brandi L Blaylock; Michael A Nader; Jack Bergman; David R Sibley; Phil Skolnick
Journal:  Biochem Pharmacol       Date:  2012-07-03       Impact factor: 5.858

6.  Active-state models of ternary GPCR complexes: determinants of selective receptor-G-protein coupling.

Authors:  Ralf C Kling; Harald Lanig; Timothy Clark; Peter Gmeiner
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation.

Authors:  Chiara Bianca Maria Platania; Salvatore Salomone; Gian Marco Leggio; Filippo Drago; Claudio Bucolo
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Authors:  Thomas M Keck; William S John; Paul W Czoty; Michael A Nader; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-03-31       Impact factor: 7.446

9.  Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.

Authors:  Subramaniam Ananthan; Surendra K Saini; Guangyan Zhou; Judith V Hobrath; Indira Padmalayam; Ling Zhai; J Robert Bostwick; Tamara Antonio; Maarten E A Reith; Shea McDowell; Eunie Cho; Leah McAleer; Michelle Taylor; Robert R Luedtke
Journal:  J Med Chem       Date:  2014-08-15       Impact factor: 7.446

10.  Structure-guided development of heterodimer-selective GPCR ligands.

Authors:  Harald Hübner; Tamara Schellhorn; Marie Gienger; Carolin Schaab; Jonas Kaindl; Laurin Leeb; Timothy Clark; Dorothee Möller; Peter Gmeiner
Journal:  Nat Commun       Date:  2016-07-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.